Glenmark Pharmaceuticals Limited — Others, 14-08-2025: Change in Director(s)

Glenmark Pharma's Board has approved transferring its Consumer Care business to a new wholly-owned subsidiary, Glenmark Consumer Care Limited, for approximately INR 240.40 Cr. This strategic move aims for sharper focus and value creation in the growing consumer care sector. The consumer business contributed INR 514.7 Cr to turnover and INR 249.2 Cr to net worth last fiscal year. Additionally, the Board appointed Ms. Patricia Andrews as an independent director, bringing extensive pharma and biotech leadership experience. The company also appointed new Statutory Auditors (Walker Chandiok & Co. LLP) and Secretarial Auditors, and will hold its 47th Annual General Meeting soon.